Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Sales | 17,976 | 15,937 | 13,036 | 10,312 | 11,791 |
| Cost of Goods | 8,434 | 7,343 | 8,774 | 5,479 | 4,844 |
| Gross Profit | 9,542 | 8,594 | 4,262 | 4,833 | 6,947 |
| Operating Expenses | 3,641 | 4,312 | 3,593 | 3,664 | 3,176 |
| Operating Income | 5,901 | 4,282 | 669 | 1,169 | 3,771 |
| Interest Expense | 1,137 | 1,111 | 1,214 | 1,122 | 1,094 |
| Other Income | -133 | -243 | -73 | -44 | -123 |
| Pre-tax Income | 4,632 | 2,929 | -618 | 3 | 2,553 |
| Net Income Continuous | 4,632 | 2,929 | -618 | 3 | 2,553 |
| Net Income | $4,632 | $2,929 | $-618 | $3 | $2,553 |
| EPS Basic Total Ops | 0.05 | 0.03 | -0.01 | 0.00 | 0.20 |
| EPS Basic Continuous Ops | 0.05 | 0.03 | -0.01 | 0.00 | 0.20 |
| EPS Diluted Total Ops | 0.05 | 0.03 | -0.01 | 0.00 | 0.20 |
| EPS Diluted Continuous Ops | 0.05 | 0.03 | -0.01 | 0.00 | 0.20 |
| EBITDA(a) | $7,086 | $5,319 | $1,774 | $2,292 | $4,784 |